175 related articles for article (PubMed ID: 11042224)
1. Rational selection of antisense oligonucleotide sequences.
Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
[TBL] [Abstract][Full Text] [Related]
2. Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.
Gabler A; Krebs S; Seichter D; Förster M
Nucleic Acids Res; 2003 Aug; 31(15):e79. PubMed ID: 12888531
[TBL] [Abstract][Full Text] [Related]
3. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
[TBL] [Abstract][Full Text] [Related]
4. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
[TBL] [Abstract][Full Text] [Related]
6. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
[TBL] [Abstract][Full Text] [Related]
7. Design of antisense and triplex-forming oligonucleotides.
François JC; Lacoste J; Lacroix L; Mergny JL
Methods Enzymol; 2000; 313():74-95. PubMed ID: 10595350
[No Abstract] [Full Text] [Related]
8. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
[TBL] [Abstract][Full Text] [Related]
9. Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity.
Matveeva OV; Tsodikov AD; Giddings M; Freier SM; Wyatt JR; Spiridonov AN; Shabalina SA; Gesteland RF; Atkins JF
Nucleic Acids Res; 2000 Aug; 28(15):2862-5. PubMed ID: 10908347
[TBL] [Abstract][Full Text] [Related]
10. The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.
Lima WF; Mohan V; Crooke ST
J Biol Chem; 1997 Jul; 272(29):18191-9. PubMed ID: 9218455
[TBL] [Abstract][Full Text] [Related]
11. Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding.
Jaroszewski JW; Syi JL; Ghosh M; Ghosh K; Cohen JS
Antisense Res Dev; 1993; 3(4):339-48. PubMed ID: 8155975
[TBL] [Abstract][Full Text] [Related]
12. Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.
Kandimalla ER; Manning A; Lathan C; Byrn RA; Agrawal S
Nucleic Acids Res; 1995 Sep; 23(17):3578-84. PubMed ID: 7567472
[TBL] [Abstract][Full Text] [Related]
13. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
[TBL] [Abstract][Full Text] [Related]
14. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
15. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
16. A ribonuclease H-oligo DNA conjugate that specifically cleaves hepatitis B viral messenger RNA.
Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2001; 12(5):770-5. PubMed ID: 11562195
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of gene expression using ribonuclease P and external guide sequences.
Guerrier-Takada C; Altman S
Methods Enzymol; 2000; 313():442-56. PubMed ID: 10595372
[No Abstract] [Full Text] [Related]
18. Basic principles of using antisense oligonucleotides in vivo.
Phillips MI; Zhang YC
Methods Enzymol; 2000; 313():46-56. PubMed ID: 10595348
[No Abstract] [Full Text] [Related]
19. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
Delihas N; Rokita SE; Zheng P
Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
[TBL] [Abstract][Full Text] [Related]
20. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
